Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,59 USD | -0,62% | -4,79% | +2,58% |
Attività
Numero di dipendenti: 121
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Probody Therapeutics
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01/12/10 |
Chris Ogden
DFI | Director of Finance/CFO | 40 | 02/08/21 |
Marcia Belvin
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/01/18 |
Yu Waye Chu
CTO | Chief Tech/Sci/R&D Officer | 56 | 17/07/23 |
Lloyd Rowland
CMP | Compliance Officer | 67 | 01/05/18 |
Jeffrey Landau
PRN | Corporate Officer/Principal | 46 | 01/04/21 |
Hong He
PRN | Corporate Officer/Principal | 55 | 01/02/20 |
Danielle Olander
HRO | Human Resources Officer | - | 01/08/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
James Meyers
BRD | Director/Board Member | 58 | 20/12/18 |
Elaine Jones
BRD | Director/Board Member | 69 | 01/12/14 |
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01/12/10 |
Mani Mohindru
BRD | Director/Board Member | 52 | 16/12/20 |
Halley Gilbert
BRD | Director/Board Member | 54 | 27/04/20 |
Matthew Young
BRD | Director/Board Member | 54 | 01/11/15 |
Alan Ashworth
BRD | Director/Board Member | 63 | 29/09/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 67 731 764 | 66 926 077 ( 98,81 %) | 0 | 98,81 % |
Coordinate società
CytomX Therapeutics, Inc.
151 Oyster Point Boulevard Suite 400
94080-1913, South San Francisco
+650 515 3185
http://www.cytomx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+2,58% | 108 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione CTMX
- Società CytomX Therapeutics, Inc.